The growth factor–regulated PI3K-Akt (also known as PKB) signalling cascade is one of the most frequently dysregulated pathways in cancer, resulting commonly in an upregulation of Akt and thereby an attenuation of FOXO activity [94]. This evidence concerns the gene AKT1 and cancer.